Green Thumb Industries (GTBIF) Total Liabilities (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Total Liabilities came in at $934.6 million in Q1 2026, up 22.53% YoY from $762.7 million in Q1 2025, and up 6.27% on a QoQ basis from $879.4 million in Q4 2025.
Green Thumb Industries (GTBIF) Total Liabilities (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Total Liabilities data on file, last reported at $934.6 million in Q1 2026.
- Quarterly Total Liabilities rose 22.53% year-over-year to $934.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $934.6 million (up 22.53% YoY) and the FY2025 annual result came in at $879.4 million, up 17.58% from the prior year.
- Total Liabilities climbed to $934.6 million in Q1 2026, from $879.4 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $934.6 million in Q1 2026 to a low of $740.2 million in Q3 2024.
- A 5-year average of $789.3 million and a median of $786.6 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 66.27% — and 2024, when it decreased 6.58%.
- Tracing GTBIF's Total Liabilities over 5 years: stood at $768.1 million in 2022, then gained by 2.44% to $786.8 million in 2023, then retreated by 4.94% to $747.9 million in 2024, then advanced by 17.58% to $879.4 million in 2025, then climbed by 6.27% to $934.6 million in 2026.
- The last three Total Liabilities figures came in at $934.6 million (Q1 2026), $879.4 million (Q4 2025), and $804.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 954.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 954.64 Mn |
| Mar 31, 2026 | 934.56 Mn |
| Dec 31, 2025 | 879.41 Mn |
| Sep 30, 2025 | 804.28 Mn |
| Jun 30, 2025 | 748.82 Mn |
| Mar 31, 2025 | 762.74 Mn |
| Dec 31, 2024 | 747.93 Mn |
| Sep 30, 2024 | 740.15 Mn |
| Jun 30, 2024 | 786.60 Mn |
| Mar 31, 2024 | 807.69 Mn |
| Dec 31, 2023 | 786.80 Mn |
| Sep 30, 2023 | 792.31 Mn |
| Jun 30, 2023 | 807.02 Mn |
| Mar 31, 2023 | 812.02 Mn |
| Dec 31, 2022 | 768.10 Mn |
| Sep 30, 2022 | 749.07 Mn |
| Jun 30, 2022 | 748.35 Mn |
| Mar 31, 2022 | 742.16 Mn |
| Dec 31, 2021 | 766.37 Mn |
| Sep 30, 2021 | 705.31 Mn |